Recherche
Résultats 1-10 de 188
-
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (regosarc): a randomised, double-blind, placebo-controlled, phase 2 trial
The Lancet. Oncology, 01-12-2016, 17, 1732-1742Article dans une revue scientifique -
Irrecist and irecist: the devil is in the details
Annals of oncology . official journal of the European Society for Medical Oncology, 01-07-2017, 28, 1676-1678Article dans une revue scientifique -
Incidence and risk factors for ifosfamide-related encephalopathy in sarcoma patients
Bulletin du cancer, 01-03-2017, 104, 208-212Article dans une revue scientifique -
A randomized, double-blind, placebo-controlled phase ii study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy
Annals of oncology . official journal of the European Society for Medical Oncology, 01-11-2017, 28, 2741-2746Article dans une revue scientifique -
How to emerge from the conservatism in clinical research methodology?
Current opinion in oncology, 01-09-2017, 29, 400-404Article dans une revue scientifique -
Which recent results in oncology and hematology will have an impact on our practices? the point of vue of bulletin du cancer editorial board
Bulletin du cancer, 01-01-2017, 104, 6-19Article dans une revue scientifique -
Trabectedin is an effective second-line treatment in soft tissue sarcoma patients
Annals of oncology . official journal of the European Society for Medical Oncology, 01-03-2016, 27, 551-552Article dans une revue scientifique -
Factual understanding of randomized clinical trials: a multicenter case-control study in cancer patients
Investigational New Drugs, Springer Verlag, 2011, 24, 891-705Article dans une revue scientifique -
Surgery in reference centers improves survival of sarcoma patients: a nationwide study
Annals of oncology . official journal of the European Society for Medical Oncology, 05-06-2019, 30 (7), 1143-1153Article dans une revue scientifiquetexte intégral -
Activity and safety of palbociclib in patients with advanced gastrointestinal stromal tumors refractory to imatinib and sunitinib: a biomarker-driven phase 2 study
Clinical cancer research . an official journal of the American Association for Cancer Research, 12-04-2019Article dans une revue scientifique